Journal of the American Chemical Society, ISSN 0002-7863, 10/2017, Volume 139, Issue 39, pp. 13922 - 13928
In the framework of modern energy challenges, the reduction of CO into fuels calls for electrogenerated low-valent transition metal complexes catalysts...
Chemical Sciences | Catalysis
Chemical Sciences | Catalysis
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 10/2017, Volume 139, Issue 39, pp. 13922 - 13928
In the framework of modern energy challenges, the reduction of CO2 into fuels calls for electrogenerated low-valent transition metal complexes catalysts...
HYDROGEN | ELECTROCATALYTIC REDUCTION | METHANOL | ACID | CONVERSION | PORPHYRINS | COMPLEXES | ELECTRODES | CARBON-DIOXIDE | CHEMISTRY, MULTIDISCIPLINARY | COBALT | Electrochemistry | Voltammetry | Usage | Research | Chemical properties | Carbon dioxide
HYDROGEN | ELECTROCATALYTIC REDUCTION | METHANOL | ACID | CONVERSION | PORPHYRINS | COMPLEXES | ELECTRODES | CARBON-DIOXIDE | CHEMISTRY, MULTIDISCIPLINARY | COBALT | Electrochemistry | Voltammetry | Usage | Research | Chemical properties | Carbon dioxide
Journal Article
Journal of Applied Biosciences, ISSN 1997-5902, 03/2019, Volume 133, Issue 1, p. 13542
Journal Article
AIDS, ISSN 0269-9370, 2014, Volume 28, Issue 8, pp. 1161 - 1169
Objective: To assess the virological response, genotypic resistance profiles, and antiretroviral plasma concentrations in HIV-2 antiretroviral-treated...
Côte d'Ivoire | HIV-2 | Plasma drug concentrations | Antiretroviral resistance | VIRAL LOAD | INFECTIOUS DISEASES | Cote d'Ivoire | IMMUNOLOGY | PROTEASE INHIBITORS | HIV-2-INFECTED PATIENTS | SENEGAL IMPLICATIONS | IN-VITRO | antiretroviral resistance | REVERSE-TRANSCRIPTASE INHIBITORS | VIROLOGY | VITRO PHENOTYPIC SUSCEPTIBILITY | plasma drug concentrations | ANTIRETROVIRAL DRUG-RESISTANCE | HIV-2 INFECTION | IMMUNODEFICIENCY-VIRUS TYPE-2 | Anti-Retroviral Agents - therapeutic use | Cross-Sectional Studies | HIV Infections - genetics | Humans | Middle Aged | Genotype | Male | Treatment Outcome | Mutation - genetics | Viral Load | Sequence Analysis, RNA - methods | Drug Resistance, Viral - genetics | Adult | Female | HIV Infections - drug therapy | HIV-2 - genetics | Anti-Retroviral Agents - blood | Patient Compliance | Chromatography, Liquid - methods | Tandem Mass Spectrometry - methods | Côte d’Ivoire
Côte d'Ivoire | HIV-2 | Plasma drug concentrations | Antiretroviral resistance | VIRAL LOAD | INFECTIOUS DISEASES | Cote d'Ivoire | IMMUNOLOGY | PROTEASE INHIBITORS | HIV-2-INFECTED PATIENTS | SENEGAL IMPLICATIONS | IN-VITRO | antiretroviral resistance | REVERSE-TRANSCRIPTASE INHIBITORS | VIROLOGY | VITRO PHENOTYPIC SUSCEPTIBILITY | plasma drug concentrations | ANTIRETROVIRAL DRUG-RESISTANCE | HIV-2 INFECTION | IMMUNODEFICIENCY-VIRUS TYPE-2 | Anti-Retroviral Agents - therapeutic use | Cross-Sectional Studies | HIV Infections - genetics | Humans | Middle Aged | Genotype | Male | Treatment Outcome | Mutation - genetics | Viral Load | Sequence Analysis, RNA - methods | Drug Resistance, Viral - genetics | Adult | Female | HIV Infections - drug therapy | HIV-2 - genetics | Anti-Retroviral Agents - blood | Patient Compliance | Chromatography, Liquid - methods | Tandem Mass Spectrometry - methods | Côte d’Ivoire
Journal Article
Journal of Threatened Taxa, ISSN 0974-7893, 04/2019, Volume 11, Issue 6, pp. 13654 - 13666
To improve the knowledge of non-volant mammal diversity and conservation prospects in the Dodo Coastal Forest (DCF) in southwestern Côte d’Ivoire, we conducted...
Journal Article
Tropical Medicine & International Health, ISSN 1360-2276, 06/2019, Volume 24, Issue 6, pp. 775 - 785
Summary Objective To describe growth evolution and its correlates in the first 5 years of antiretroviral therapy (ART) initiation among HIV‐infected children...
malnutrition | HIV | VIH | antiretroviral therapy | croissance | growth | traitement antirétroviral | enfant | child | Highly active antiretroviral therapy | Antiviral agents | Pediatrics | Growth | Analysis | HIV patients | Children | HIV (Viruses) | HIV infection | Therapy | Anthropometry | Immunodeficiency | Cohorts | Weight | Girls | Antiretroviral therapy | Body height | Body mass | Antiretroviral agents | Correlation analysis | Human immunodeficiency virus--HIV | Evolution | Heat affected zone | Height | Malnutrition | Drug therapy | Age
malnutrition | HIV | VIH | antiretroviral therapy | croissance | growth | traitement antirétroviral | enfant | child | Highly active antiretroviral therapy | Antiviral agents | Pediatrics | Growth | Analysis | HIV patients | Children | HIV (Viruses) | HIV infection | Therapy | Anthropometry | Immunodeficiency | Cohorts | Weight | Girls | Antiretroviral therapy | Body height | Body mass | Antiretroviral agents | Correlation analysis | Human immunodeficiency virus--HIV | Evolution | Heat affected zone | Height | Malnutrition | Drug therapy | Age
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2016, Volume 11, Issue 4, p. e0153243
World Health Organization advocates for integration of HIV-tuberculosis (TB) services and recommends intensive case finding (ICF), isoniazid preventive therapy...
South America | Poverty | World Health Organization | Humans | AIDS-Related Opportunistic Infections - drug therapy | Africa | Infection Control | AIDS-Related Opportunistic Infections - diagnosis | Caribbean Region | Tuberculosis - diagnosis | AIDS-Related Opportunistic Infections - prevention & control | Asia | Tuberculosis - drug therapy | Tuberculosis - prevention & control | HIV Infections - complications | HIV Infections - drug therapy | Isoniazid - therapeutic use | Antitubercular Agents - therapeutic use | Prevention | Complications and side effects | Usage | Tuberculosis | Dosage and administration | Research | Diagnosis | Drug therapy | Medicine, Preventive | Isoniazid | Preventive health services | Health care | Medical personnel | Therapy | Integration | Income | Infections | Tuberculin | Preventive medicine | Medical diagnosis | Patients | Masks | Studies | Screening | Acquired immune deficiency syndrome--AIDS | Workers | Collaboration | Human immunodeficiency virus--HIV | Smear | Occupational health | Skin | Skin tests | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
South America | Poverty | World Health Organization | Humans | AIDS-Related Opportunistic Infections - drug therapy | Africa | Infection Control | AIDS-Related Opportunistic Infections - diagnosis | Caribbean Region | Tuberculosis - diagnosis | AIDS-Related Opportunistic Infections - prevention & control | Asia | Tuberculosis - drug therapy | Tuberculosis - prevention & control | HIV Infections - complications | HIV Infections - drug therapy | Isoniazid - therapeutic use | Antitubercular Agents - therapeutic use | Prevention | Complications and side effects | Usage | Tuberculosis | Dosage and administration | Research | Diagnosis | Drug therapy | Medicine, Preventive | Isoniazid | Preventive health services | Health care | Medical personnel | Therapy | Integration | Income | Infections | Tuberculin | Preventive medicine | Medical diagnosis | Patients | Masks | Studies | Screening | Acquired immune deficiency syndrome--AIDS | Workers | Collaboration | Human immunodeficiency virus--HIV | Smear | Occupational health | Skin | Skin tests | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Epidemiology and Health, 11/2018, Volume 40
OBJECTIVES To describe the emergence of Neisseria meningitidis (Nm) W135 in Côte d’Ivoire and its characteristics compared to NmA. METHODS Data on Nm samples...
Public health surveillance | Cote d’Ivoire | Bacterial meningitis
Public health surveillance | Cote d’Ivoire | Bacterial meningitis
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, p. e66135
Background: HIV-2 is endemic in West Africa. There is a lack of evidence-based guidelines on the diagnosis, management and antiretroviral therapy (ART) for...
HIV-2-INFECTED INDIVIDUALS | INTERNATIONAL COLLABORATION | RALTEGRAVIR | MULTIDISCIPLINARY SCIENCES | IMMUNOLOGICAL RESPONSE | INFECTION | DRUG-RESISTANCE | TYPE-1 HIV-1 | DIFFERENTIATION | INHIBITORS | TO-CHILD TRANSMISSION | Africa, Western - epidemiology | HIV-1 - isolation & purification | HIV-2 - isolation & purification | HIV Infections - virology | Humans | Middle Aged | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Male | Cohort Studies | Infection | Antiviral agents | Highly active antiretroviral therapy | Analysis | HIV (Viruses) | Health aspects | Evidence-based medicine | Epidemiology | Medical research | Antiretroviral drugs | Therapy | Clinical trials | Infections | Medical diagnosis | Patients | Antiretroviral therapy | CD4 antigen | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Collaboration | Adults | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
HIV-2-INFECTED INDIVIDUALS | INTERNATIONAL COLLABORATION | RALTEGRAVIR | MULTIDISCIPLINARY SCIENCES | IMMUNOLOGICAL RESPONSE | INFECTION | DRUG-RESISTANCE | TYPE-1 HIV-1 | DIFFERENTIATION | INHIBITORS | TO-CHILD TRANSMISSION | Africa, Western - epidemiology | HIV-1 - isolation & purification | HIV-2 - isolation & purification | HIV Infections - virology | Humans | Middle Aged | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Male | Cohort Studies | Infection | Antiviral agents | Highly active antiretroviral therapy | Analysis | HIV (Viruses) | Health aspects | Evidence-based medicine | Epidemiology | Medical research | Antiretroviral drugs | Therapy | Clinical trials | Infections | Medical diagnosis | Patients | Antiretroviral therapy | CD4 antigen | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Collaboration | Adults | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
10.
Full Text
Emergence of Neisseria meningitidis W135 in Cote d'Ivoire: laboratory based-surveillance
Epidemiology and health, 2018, Volume 40, p. e2018058
To describe the emergence of Neisseria meningitidis (Nm) W135 in Côte d'Ivoire and its characteristics compared to NmA. Data on Nm samples isolated at the...
Cote d’Ivoire | Neisseria meningitidis | Bacterial meningitis | Public health surveillance | Neisseria meningitidis, Serogroup W-135 - isolation & purification | Communicable Diseases, Emerging - microbiology | Meningitis, Meningococcal - diagnosis | Clinical Laboratory Techniques | Humans | Child, Preschool | Infant | Male | Communicable Diseases, Emerging - epidemiology | Cote d'Ivoire - epidemiology | Meningitis, Meningococcal - epidemiology | Public Health Surveillance - methods | Adolescent | Female | Child
Cote d’Ivoire | Neisseria meningitidis | Bacterial meningitis | Public health surveillance | Neisseria meningitidis, Serogroup W-135 - isolation & purification | Communicable Diseases, Emerging - microbiology | Meningitis, Meningococcal - diagnosis | Clinical Laboratory Techniques | Humans | Child, Preschool | Infant | Male | Communicable Diseases, Emerging - epidemiology | Cote d'Ivoire - epidemiology | Meningitis, Meningococcal - epidemiology | Public Health Surveillance - methods | Adolescent | Female | Child
Journal Article
11.
Full Text
Emergence of Neisseria meningitidis W135 in Cote d’Ivoire: laboratory based-surveillance
Epidemiology and Health, ISSN 2092-7193, 11/2018, Volume 40, p. e2018058
Journal Article
AIDS, ISSN 0269-9370, 07/2014, Volume 28, Issue 11, pp. 1645 - 1655
Objective: We describe the association between age at antiretroviral therapy (ART) initiation and 24-month CD4(+) cell response in West African HIV-infected...
Immune reconstitution | Children | HIV | West Africa | Antiretroviral therapy | MORTALITY | INFECTIOUS DISEASES | ABIDJAN | COTE-DIVOIRE | antiretroviral therapy | CD4(+) cell | immune reconstitution | IMMUNOLOGY | VIROLOGY | MORBIDITY | children | CD4 CELL RESPONSE | OUTCOMES | PROGRAM | west Africa | Anti-Retroviral Agents - therapeutic use | Age Factors | Humans | Child, Preschool | Infant | Male | Treatment Outcome | CD4 Lymphocyte Count | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Sex Factors | Female | HIV Infections - drug therapy | Child | Africa, Western | Life Sciences | Santé publique et épidémiologie
Immune reconstitution | Children | HIV | West Africa | Antiretroviral therapy | MORTALITY | INFECTIOUS DISEASES | ABIDJAN | COTE-DIVOIRE | antiretroviral therapy | CD4(+) cell | immune reconstitution | IMMUNOLOGY | VIROLOGY | MORBIDITY | children | CD4 CELL RESPONSE | OUTCOMES | PROGRAM | west Africa | Anti-Retroviral Agents - therapeutic use | Age Factors | Humans | Child, Preschool | Infant | Male | Treatment Outcome | CD4 Lymphocyte Count | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Sex Factors | Female | HIV Infections - drug therapy | Child | Africa, Western | Life Sciences | Santé publique et épidémiologie
Journal Article
BMC Infectious Diseases, 08/2015, Volume 15, Issue 1, p. 317
Background: Cotrimoxazole prophylaxis has an antimalarial effect which could have an additional protective effect against malaria in HIV-infected children on...
Cotrimoxazole | Children | HIV | Malaria | Antiretroviral therapy | Africa | MORTALITY | INFECTIOUS DISEASES | HIV-1-INFECTED ADULTS | UGANDA | IMPACT | IMMUNOSUPPRESSION | INSECTICIDE-TREATED BEDNETS | DISEASE | PROGRAM | TRIMETHOPRIM-SULFAMETHOXAZOLE | Prospective Studies | Follow-Up Studies | Humans | Child, Preschool | Male | Antimalarials - therapeutic use | Cote d'Ivoire - epidemiology | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Incidence | Regression Analysis | Malaria - epidemiology | HIV Infections - complications | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Malaria - complications | Malaria - drug therapy | Child | Cohort Studies
Cotrimoxazole | Children | HIV | Malaria | Antiretroviral therapy | Africa | MORTALITY | INFECTIOUS DISEASES | HIV-1-INFECTED ADULTS | UGANDA | IMPACT | IMMUNOSUPPRESSION | INSECTICIDE-TREATED BEDNETS | DISEASE | PROGRAM | TRIMETHOPRIM-SULFAMETHOXAZOLE | Prospective Studies | Follow-Up Studies | Humans | Child, Preschool | Male | Antimalarials - therapeutic use | Cote d'Ivoire - epidemiology | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Incidence | Regression Analysis | Malaria - epidemiology | HIV Infections - complications | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Malaria - complications | Malaria - drug therapy | Child | Cohort Studies
Journal Article